"Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August... To become the next President of the United States. When you see who, you'll be terrified... Because if I'm right about the election outcome... I'm recommending every American make urgent moves with their money right now." --Louis Navellier
"If you're not at the table, you're on the menu," says former Goldman Sachs VP, Dr. David Eifrig.
It's not Nvidia, Meta Platforms, Alphabet, or Amazon. But thanks to a recent major deal, an under-the-radar stock could become the No. 1 winner of the AI boom. "This company just teamed up with one of the biggest power players in the AI industry... yet you can still buy it for just one-twelfth the price of Nvidia -- the time to buy is NOW," says Marc Chaikin.
According to one early A.I. pioneer: "You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There's no middle option."
Hardly any investors are talking about this coin but I believe that's about to change with some potentially huge news! Get in on the ground floor while it's rock bottom with this new how-to guide, just $3.
A Big Pharma giant quietly bought one AI-designed drug for $4 billion designed by a tiny AI-biotech company. Wall Street doesn't yet grasp how this company is quietly revolutionizing the drug discovery business but this won't stay quiet much longer.